This brand name is authorized in Malta
The drug POSIFORLID contains one active pharmaceutical ingredient (API):
|
1
Bibrocathol
UNII 0KJ20H1BLJ - BIBROCATHOL
|
|
Bibrocathol is a bismuth-containing substance which acts as antiseptic, adstringent and secretion inhibitng agent on mucous membranes and wounds. The mechanism of action is explained by its phenolic molecular structure consisting of tetrabromopyrocatechol and bismuth hydroxide that causes the precipitation of proteins and the shrinking of superficial layers of tissue. These activities result in the formation of a protective membrane against pathogenic invasion and non-specifically inhibit inflammation and secretion. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| POSIFORLID Eye ointment | Medicines Authority (MT) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| S01AX05 | Bibrocathol | S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AX Other antiinfectives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: MT | Medicines Authority | Identifier(s): MA063/01101 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
